NO20020784L - Medikament for behandling av brudd - Google Patents

Medikament for behandling av brudd

Info

Publication number
NO20020784L
NO20020784L NO20020784A NO20020784A NO20020784L NO 20020784 L NO20020784 L NO 20020784L NO 20020784 A NO20020784 A NO 20020784A NO 20020784 A NO20020784 A NO 20020784A NO 20020784 L NO20020784 L NO 20020784L
Authority
NO
Norway
Prior art keywords
fractures
medication
treatment
Prior art date
Application number
NO20020784A
Other languages
English (en)
Norwegian (no)
Other versions
NO20020784D0 (no
Inventor
David G Little
Original Assignee
Royal Alexandra Hosp Children
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Royal Alexandra Hosp Children filed Critical Royal Alexandra Hosp Children
Publication of NO20020784L publication Critical patent/NO20020784L/no
Publication of NO20020784D0 publication Critical patent/NO20020784D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A61K31/6615—Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20020784A 1999-08-19 2002-02-18 Medikament for behandling av brudd NO20020784D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPQ2325A AUPQ232599A0 (en) 1999-08-19 1999-08-19 Drug for treating fractures
PCT/AU2000/000982 WO2001013922A1 (en) 1999-08-19 2000-08-17 Drug for treating fractures

Publications (2)

Publication Number Publication Date
NO20020784L true NO20020784L (no) 2002-02-18
NO20020784D0 NO20020784D0 (no) 2002-02-18

Family

ID=3816500

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20020784A NO20020784D0 (no) 1999-08-19 2002-02-18 Medikament for behandling av brudd

Country Status (16)

Country Link
EP (1) EP1214079A4 (pt)
JP (1) JP2003507426A (pt)
KR (1) KR20020027562A (pt)
CN (1) CN100345548C (pt)
AU (1) AUPQ232599A0 (pt)
BR (1) BR0013416A (pt)
CA (1) CA2381302A1 (pt)
HK (1) HK1048441B (pt)
HU (1) HUP0202396A3 (pt)
IL (1) IL148166A0 (pt)
NO (1) NO20020784D0 (pt)
NZ (1) NZ517538A (pt)
PL (1) PL353485A1 (pt)
SK (1) SK2382002A3 (pt)
WO (1) WO2001013922A1 (pt)
ZA (1) ZA200202160B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002221339B2 (en) 2001-02-06 2006-04-27 The Sydney Children's Hospitals Network (Randwick And Westmead) (Incorporating The Royal Alexandra Hospital For Children) A drug for the treatment of osteonecrosis and for the management of patients at risk of developing osteonecrosis
JP2004526747A (ja) * 2001-04-03 2004-09-02 ザ ロイヤル アレクサンドラ ホスピタル フォー チルドレン 骨移植で使用される医薬
AUPR553701A0 (en) * 2001-06-07 2001-07-12 Royal Alexandra Hospital For Children, The A device for the delivery of a drug to a fractured bone
ES2561463T3 (es) * 2003-08-21 2016-02-26 Addbio Ab Dispositivo de implante recubierto con bisfosfonato y método para el mismo
JP2007505886A (ja) * 2003-09-19 2007-03-15 ファイザー・プロダクツ・インク ２−メチレン−１９−ノル−ビタミンｄ誘導体及びビスホスフォネートの組み合わせを含む医薬組成物及び方法
ITMI20040218A1 (it) * 2004-02-10 2004-05-10 Abiogen Pharma Spa Uso di neridronato sodico per promuovere la neoformazione ossea
ITMI20040641A1 (it) * 2004-03-31 2004-06-30 Tb Technology S R L Composizioni bioadesive bifunzionali per implantologia orale
AR048742A1 (es) * 2004-12-22 2006-05-24 Gador Sa Sistema de aplicacion de medicamentos intra-oral
EP1940339B1 (de) * 2005-10-27 2011-12-21 Thommen Medical Ag Dentalimplantat und verfahren zu dessen herstellung
US8882740B2 (en) 2009-12-23 2014-11-11 Stryker Trauma Gmbh Method of delivering a biphosphonate and/or strontium ranelate below the surface of a bone
CN114532937A (zh) * 2020-11-18 2022-05-27 中国人民解放军海军军医大学第一附属医院 一种小肠镜辅助装置

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR8107560A (pt) * 1981-11-19 1983-07-05 Luiz Romariz Duarte Estimulacao ultra-sonica da consolidacao de fraturas osseas
SK74594A3 (en) * 1991-12-17 1995-01-12 Procter & Gamble Pharma Treatment for treating of osteoporosis
AU670337B2 (en) * 1992-11-30 1996-07-11 Novartis Ag Use of certain methanebisphosphonic acid derivatives in fracture healing
EP0600834A1 (en) * 1992-11-30 1994-06-08 Ciba-Geigy Ag Use of methanebisphosphonic acid derivatives for the manufacture of a medicament for fracture healing
WO1994014455A1 (en) * 1992-12-23 1994-07-07 Merck & Co., Inc. Bisphosphonate/estrogen therapy for treating and preventing bone loss
US5403829A (en) * 1993-03-24 1995-04-04 Leiras Oy Use of bisphosphonates in endo-osteal bone surgery
US5646134A (en) * 1994-04-21 1997-07-08 Merck & Co., Inc. Alendronate therapy to prevent loosening of, or pain associated with, orthopedic implant devices
GB9408775D0 (en) * 1994-05-04 1994-06-22 Ciba Geigy Ag Use of certain methanebisphosphonic acid derivatives to prevent prothesis loosening and prothesis migration
US5616571A (en) * 1995-06-06 1997-04-01 Merck & Co., Inc. Bisphosphonates prevent bone loss associated with immunosuppressive therapy
WO1996039150A1 (en) * 1995-06-06 1996-12-12 Merck & Co., Inc. Bisphosphonate therapy for bone loss associated with rheumatoid arthritis
US5853759A (en) * 1996-05-17 1998-12-29 Merck & Co.. Inc. Effervescent alendronate formulation
GB9613722D0 (en) * 1996-06-28 1996-08-28 Univ Liverpool Chemical compounds

Also Published As

Publication number Publication date
CN1370071A (zh) 2002-09-18
ZA200202160B (en) 2003-08-27
HUP0202396A2 (hu) 2002-11-28
IL148166A0 (en) 2002-09-12
AUPQ232599A0 (en) 1999-09-09
SK2382002A3 (en) 2002-09-10
CN100345548C (zh) 2007-10-31
HK1048441A1 (en) 2003-04-04
NO20020784D0 (no) 2002-02-18
HK1048441B (zh) 2008-02-22
NZ517538A (en) 2003-07-25
BR0013416A (pt) 2002-04-30
JP2003507426A (ja) 2003-02-25
PL353485A1 (en) 2003-11-17
HUP0202396A3 (en) 2005-02-28
WO2001013922A1 (en) 2001-03-01
KR20020027562A (ko) 2002-04-13
CA2381302A1 (en) 2001-03-01
EP1214079A1 (en) 2002-06-19
EP1214079A4 (en) 2004-03-24

Similar Documents

Publication Publication Date Title
NO20013380L (no) 2-aminobenzoksazinonderivater for behandling av fedme
NO20052894D0 (no) 4-tetrazolyl-4-fenylpiperidin-derivater for behandling av smerte
NO20013369D0 (no) Arylpiperazinyl-cykloheksyl-indol-derivater for behandling av depresjon
NO20014379D0 (no) Anvendelse av Xenon for behandling av Neurointoksikasjoner
DE60142473D1 (de) Intrakorporale medikamente zur photodynamischen behandlung von erkrankungen
NO20022087L (no) Fremgangsmåte for behandling av diabetes
IL196301A0 (en) Medicament for the treatment of hapatitis c
NO20006630D0 (no) Farmasöytisk sammensetning for behandlingen av diabetes
ATE447947T1 (de) Pharmazeutische zubereitungen zur behandlung von insulinresitenz
NO20013381D0 (no) 2-oksybenzoksazinonderivater for behandling av fedme
NO20024775D0 (no) Hydroksyfenyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte
NO20013958L (no) Legemiddel for behandling av höyt blodtrykk
NO20005179D0 (no) Medikament behandling
NO20020784D0 (no) Medikament for behandling av brudd
NO20024776L (no) Hydroksyfenyl-piperazinyl-metyl-benzamid derivater til behandling av smerte
NO20024777D0 (no) Kinolinyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte
NO20012106D0 (no) Middel for behandling av benpatobolisme
NO20012541D0 (no) Anvendelse av fosfonomaursyrederivater for behandling av infeksjoner
NO20012612L (no) Isonipecotamider for behandlingen av integrin-formidlede sykdommer
NO20013651D0 (no) Anvendelse av fosfororganiske forbindelser for profylaktisk og terapeutisk behandling av infeksjoner
PT1200447E (pt) Oxazinocarbazoles para o tratamento de doencas do snc
NO20014026L (no) Krampestillende derivater til behandling av betydelig skjelving
IS2153B (is) S-nítrósóþíól til meðferðar við blóðrásartruflunum
NO20012540D0 (no) Anvendelse av fosfonomaursyrederivater for behandling av infeksjoner
NO20014477D0 (no) Behandling av osteoartritis

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application